SCHEMBL28857607

SCHEMBL28857607

Cc1cc(C)n(Cc2ccc(C(=O)Nc3ccc(F)c(C)c3)s2)n1

nearest known ligand 0.73

Predicted protein targets (top 12)

geneUniProtsupporting neighboursconfidence
▸ SMN1; SMN2 Q16637 3/20 0.46
▸ POLB P06746 1/20 0.46
▸ LMNA P02545 3/20 0.43
▸ HTT P42858 2/20 0.42
▸ KDM4E B2RXH2 1/20 0.41
▸ KCNJ6 P48051 1/20 0.41
▸ KCNJ5 P48544 1/20 0.41
▸ KCNJ3 P48549 1/20 0.41
▸ HPGD P15428 1/20 0.41
▸ MEN1 O00255 1/20 0.40
▸ TSHR P16473 1/20 0.40
▸ KMT2A Q03164 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29898221 1.00 SMN1; SMN2 (0.46) SMN1; SMN2POLBLMNAHTTKDM4E
SCHEMBL28857586 0.90 KMT2A (0.49) SMN1; SMN2POLBLMNAMEN1TSHR
SCHEMBL29898279 0.90 KMT2A (0.49) SMN1; SMN2POLBLMNAMEN1TSHR
SCHEMBL28857587 0.88 POLB (0.47) SMN1; SMN2POLBLMNAHTTKCNJ6
SCHEMBL29898218 0.88 POLB (0.47) SMN1; SMN2POLBLMNAHTTKCNJ6
SCHEMBL28857641 0.86 SMN1; SMN2 (0.51) SMN1; SMN2POLBLMNAHTTKDM4E
SCHEMBL29898258 0.84 POLB (0.49) SMN1; SMN2POLBLMNAHTTHPGD
SCHEMBL28857616 0.84 POLB (0.49) SMN1; SMN2POLBLMNAHTTHPGD
SCHEMBL28857590 0.84 POLB (0.51) SMN1; SMN2POLBLMNAHTTKDM4E
SCHEMBL28857620 0.83 TNIK (0.49) SMN1; SMN2POLBLMNAHTTKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-115160269-A Arylcarboxamide derivatives as positive allosteric modulators of NMDAR 北京大学 2022-10-11 — — CN claimed
CN-115160269-A Arylcarboxamide derivatives as positive allosteric modulators of NMDAR 北京大学 2022-10-11 — — CN disclosed
Send feedback